Japan to approve its first coronavirus antigen test kits on Wednesday

12.05.2020 - Davydova Maria
Japan to approve its first coronavirus antigen test kits on Wednesday

Japan is planning to approve its first COVID-19 antigen testing kits on Wednesday, according to an official from the Health Ministry. The decision comes in a bid to increase the number of diagnostic tests available to combat the pandemic.

Fujirebio Inc. had applied for government approval for its antigen kit in April. Fujirebio is a subsidiary of the Japan-based diagnostics and lab-testing provider, Miraca Holdings.

Japanese Health Minister Katsunobu Kato said on Friday that if the antigen tests are approved, it may be used to supplement PCR tests.

Japan has carried out 188 PCR tests per 100,000 people, in contrast to Italy and Germany where 3,159 and 3,044 tests were conducted respectively. The data was taken from a panel of medical experts who had advised the government last week.

According to public broadcaster NHK, Japan had around 16,680 confirmed cases with a death toll of 670.

Experts claimed that the low rate of testing had made tracing the virus challenging. This would lead to the occurrences of many in-hospital infections, disrupting facility operations.

The United States had also approved its first COVID-19 antigen kit last week and was produced by Quidel Corp.

Risk disclaimer "PROMETHEUS LTD – Trust Company Complex, Ajeltake Road, Ajeltake Island, Majuro, Republic of the Marshall Islands MH96960 is a financial services institution outside the European Union Area, which is subject to the supervision of the IFMRRC Certificate 0395 AA V0155 Trading in Forex/ CFDs and Other Derivatives is highly speculative and carries a high level of risk. It is possible to lose all your capital. 70% of trading deals can be unprofitable. These products may not be suitable for everyone and you should ensure that you understand the risks involved. Seek independent advice if necessary. Speculate only with funds that you can afford to lose. This Website may contain information in particular regarding financial services and products that could be regarded b a E.U. supervisory authority as an offer of financial services targeted in Europe. ESMA intervention measures do not apply to customers of PROMETHEUS LTD and it is your responsibility to choose a company which is most suitable for your trading needs. By clicking continue you confirm that you have read, understood and agree to the risk disclosures, terms of service, cash policies, privacy policies and this notice and that you are visiting this website on your own initiative, without any encouragement whatsoever from umarkets.ai or PROMETHEUS LTD." Cookies notification: We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we assume that you are happy with it. Read more. Continue

Help with deposit?